Proteomic profiling of x-linked muscular dystrophy

Journal of Muscle Research and Cell Motility

Volumn 30, Issue 7-8, 2009, Pages 267-279

  Lewis, Caroline ^a   Carberry, Steven ^a   Ohlendieck, Kay ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Duchenne muscular dystrophy; Exon skipping; Mass spectrometry; Mdx; Muscle degeneration; Proteomics

Indexed keywords

ADENYLATE KINASE; CALCIUM; CALSEQUESTRIN; DYSTROGLYCAN; DYSTROPHIN; ISOPROTEIN; MUSCLE PROTEIN; NEURONAL NITRIC OXIDE SYNTHASE; NOS1 PROTEIN, HUMAN;

ANIMAL; CHEMISTRY; DIAPHRAGM; DUCHENNE MUSCULAR DYSTROPHY; EXON; GENE EXPRESSION PROFILING; GENETICS; HUMAN; MASS SPECTROMETRY; METABOLISM; METHODOLOGY; MUSCULAR DYSTROPHY; PATHOLOGY; PROTEOMICS; REVIEW; UPREGULATION;

ADENYLATE KINASE; ANIMALS; CALCIUM; CALSEQUESTRIN; DIAPHRAGM; DYSTROGLYCANS; DYSTROPHIN; EXONS; GENE EXPRESSION PROFILING; HUMANS; MASS SPECTROMETRY; MUSCLE PROTEINS; MUSCULAR DYSTROPHIES; MUSCULAR DYSTROPHY, DUCHENNE; NITRIC OXIDE SYNTHASE TYPE I; PROTEIN ISOFORMS; PROTEOMICS; UP-REGULATION;

ANIMALIA;

EID: 77951023119     PISSN: 01424319     EISSN: 15732657     Source Type: Journal    
DOI: 10.1007/s10974-009-9197-6     Document Type: Review

References (93)

1. Ahn AH, Kunkel LM (1993) The structural and functional diversity of dystrophin. Nat Genet 3:283-291
2. Alagaratnam S, Mertens BJ, Dalebout JC, Deelder AM, van Ommen GJ, den Dunnen JT, 't Hoen PA (2008) Serum protein profiling in mice: identification of factor XIIIa as a potential biomarker for muscular dystrophy. Proteomics 8:1552-1563
3. Alderton JM, Steinhardt RA (2000) Calcium influx through calcium leak channels is responsible for the elevated levels of calciumdependent proteolysis in dystrophic myotubes. J Biol Chem 275:9452-9460
4. Allamand V, Campbell KP (2000) Animal models for muscular dystrophy: valuable tools for the development of therapies. Hum Mol Genet 9:2459-2467
5. Alter J, Lou F, Rabinowitz A, Yin H, Rosenfeld J, Wilton SD, Partridge TA, Lu QL (2006) Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology. Nat Med 12:175-177
6. Anderson NL, Anderson NG (2002) The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 1:845-867
7. Baker PE, Kearney JA, Gong B, Merriam AP, Kuhn DE, Porter JD, Rafael-Fortney JA (2006) Analysis of gene expression differences between utrophin/dystrophin-deficient vs mdx skeletal muscles reveals a specific upregulation of slow muscle genes in limb muscles. Neurogenetics 7:81-91
8. Bellinger AM, Reiken S, Carlson C, Mongillo M, Liu X, Rothman L, Matecki S, Lacampagne A, Marks AR (2009) Hypernitrosylated ryanodine receptor calcium release channels are leaky in dystrophic muscle. Nat Med 15:325-330
9. Borman L, Polla BS, Lotz BP, Gericke GS (1995) Expression of heat shock/stress proteins in Duchenne muscular dystrophy. Muscle Nerve 18:23-31
10. Bouchentouf M, Benabdallah BF, Tremblay JP (2004) Myoblast survival enhancement and transplantation success improvement by heat-shock treatment in mdx mice. Transplantation 77:1349-1356
11. Campbell KP (1995) Three muscular dystrophies: loss of cytoskeleton- extracellular matrix linkage. Cell 80:675-679
12. Canas B, Lopez-Ferrer D, Ramos-Fernandez A, Camafeita E, Calvo E (2006) Mass spectrometry technologies for proteomics. Brief Funct Genomic Proteomic 4:295-320
13. Capitanio D, Vasso M, Fania C, Moriggi M, Vigano A, Procacci P, Magnaghi V, Gelfi C (2009) Comparative proteomic profile of rat sciatic nerve and gastrocnemius muscle tissues in ageing by 2-D DIGE. Proteomics 9:2004-2020
14. Chen YW, Zhao P, Borup R, Hoffman EP (2000) Expression profiling in the muscular dystrophies: identification of novel aspects of molecular pathophysiology. J Cell Biol 151:1321-1336
15. Cox GF, Kunkel LM (1997) Dystrophies and heart disease. Curr Opin Cardiol 12:329-343
16. Cox J, Mann M (2007) Is proteomics the new genomics? Cell 130:395-398
17. Cullen MJ, Walsh J, Nicholson LV, Harris JB (1990) Ultrastructural localization of dystrophin in human muscle by using gold immunolabelling. Proc R Soc Lond B Biol Sci 240:197-210
18. Culligan K, Banville N, Dowling P, Ohlendieck K (2002) Drastic reduction of calsequestrin-like proteins and impaired calcium binding in dystrophic mdx muscle. J Appl Physiol 92:435-445
19. de Hoog CL, Mann M (2004) Proteomics. Annu Rev Genomics Hum Genet 5:267-293
20. de Jong WW, Leunissen JA, Voorter CE (1993) Evolution of the alpha-crystallin/small heat shock protein family. Mol Biol Evol 10:103-126
21. DiFranco M, Woods CE, Capote J, Vergara JL (2008) Dystrophic skeletal muscle fibers display alterations at the level of calcium microdomains. Proc Natl Acad Sci USA 105:14698-14703
22. Divet A, Huchet-Cadiou C (2002) Sarcoplasmic reticulum function in slow- and fast-twitch skeletal muscles from mdx mice. Pflugers Arch 444:634-643
23. Domon B, Aebersold R (2006) Mass spectrometry and protein analysis. Science 312:212-217
24. Doran P, Dowling P, Lohan J, McDonnell K, Poetsch S, Ohlendieck K (2004) Subproteomics analysis of Ca2+ -binding proteins demonstrates decreased calsequestrin expression in dystrophic mouse skeletal muscle. Eur J Biochem 271:3943-3952
25. Doran P, Martin G, Dowling P, Jockusch H, Ohlendieck K (2006a) Proteome analysis of the dystrophin-deficient MDX diaphragm reveals a drastic increase in the heat shock protein cvHsp. Proteomics 6:4610-4621
26. Doran P, Dowling P, Donoghue P, Buffini M, Ohlendieck K (2006b) Reduced expression of regucalcin in young and aged mdx diaphragm indicates abnormal cytosolic calcium handling in dystrophin-deficient muscle. Biochim Biophys Acta 1764:773-785
27. Doran P, Gannon J, O'Connell K, Ohlendieck K (2007) Proteomic profiling of animal models mimicking skeletal muscle disorders. Proteomics Clin Appl 1:1169-1184
28. Doran P, Donoghue P, O'Connell K, Gannon J, Ohlendieck K (2009a) Proteomics of skeletal muscle aging. Proteomics 9:989-1003
29. Doran P, Wilton SD, Fletcher S, Ohlendieck K (2009b) Proteomic profiling of antisense-induced exon skipping reveals reversal of pathobiochemical abnormalities in dystrophic mdx diaphragm. Proteomics 9:671-685
30. Dowling P, Culligan K, Ohlendieck K (2002) Distal mdx muscle groups exhibiting up-regulation of utrophin and rescue of dystrophin-associated glycoproteins exemplify a protected phenotype in muscular dystrophy. Naturwissenschaften 89:75-88
31. Dowling P, Lohan J, Ohlendieck K (2003) Comparative analysis of Dp427-deficient mdx tissues shows that the milder dystrophic phenotype of extraocular and toe muscle fibres is associated with a persistent expression of beta-dystroglycan. Eur J Cell Biol 82:222-230
32. Dowling P, Doran P, Ohlendieck K (2004) Drastic reduction of sarcalumenin in Dp427 (dystrophin of 427 kDa)-deficient fibres indicates that abnormal calcium handling plays a key role in muscular dystrophy. Biochem J 379:479-488
33. Durbeej M, Campbell KP (2002) Muscular dystrophies involving the dystrophin-glycoprotein complex: an overview of current mouse models. Curr Opin Genet Dev 12:349-361
34. Emery AE (2002a) The muscular dystrophies. Lancet 359:687-695
35. Emery AE (2002b) Muscular dystrophy into the new millennium. Neuromuscul Disord 12:343-349
36. Emery A, Muntoni F (2003) Duchenne muscular dystrophy, 3rd edn. Oxford University Press, Oxford
37. Ervasti JM, Sonnemann KJ (2008) Biology of the striated muscle dystrophin-glycoprotein complex. Int Rev Cytol 265:191-225
38. Ervasti JM, Ohlendieck K, Kahl SD, Gaver MG, Campbell KP (1990) Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature 345:315-319
39. Fenn JB, Mann M, Meng CK, Wong SF, Whitehouse CM (1989) Electrospray ionization for mass spectrometry of large biomolecules. Science 246:64-71
40. Ferretti R, Marques MJ, Pertille A, Neto HS (2009) Sarcoplasmicendoplasmic- reticulum Ca2+ -ATPase and calsequestrin are overexpressed in spared intrinsic laryngeal muscles of dystrophin- deficient mdx mice. Muscle Nerve 39:609-615
41. Gauthier DJ, Lazure C (2008) Complementary methods to assist subcellular fractionation in organellar proteomics. Expert Rev Proteomics 5:603-617
42. Ge Y, Molloy MP, Chamberlain JS, Andrews PC (2003) Proteomic analysis of mdx skeletal muscle: great reduction of adenylate kinase 1 expression and enzymatic activity. Proteomics 3:1895-1903
43. Ge Y, Molloy MP, Chamberlain JS, Andrews PC (2004) Differential expression of the skeletal muscle proteome in mdx mice at different ages. Electrophoresis 25:2576-2585
44. Gehrig SM, Ryall JG, Schertzer JD, Lynch GS (2008) Insulin-like growth factor-I analogue protects muscles of dystrophic mdx mice from contraction-mediated damage. Exp Physiol 93:1190-1198
45. Gervasio OL, Whitehead NP, Yeung EW, Phillips WD, Allen DG (2008) TRPC1 binds to caveolin-3 and is regulated by Src kinase-role in Duchenne muscular dystrophy. J Cell Sci 121:2246-2255
46. Goerg A, Weiss W, Dunn MJ (2004) Current two-dimensional electrophoresis technology for proteomics. Proteomics 4:3665-3685
47. Griffin JL, Des Rosiers C (2009) Applications of metabolomics and proteomics to the mdx mouse model of Duchenne muscular dystrophy: lessons from downstream of the transcriptome. Genome Med 1:32.1-32.11
48. Gulston MK, Rubtsov DV, Atherton HJ, Clarke K, Davies KE, Lilley KS, Griffin JL (2008) A combined metabolomic and proteomic investigation of the effects of a failure to express dystrophin in the mouse heart. J Proteome Res 7:2069-2077
49. Haslett JN, Sanoudou D, Kho AT, Bennett RR, Greenberg SA, Kohane IS, Beggs AH, Kunkel LM (2003) Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle. Proc Natl Acad Sci USA 99:15000-15005
50. Henry MD, Campbell KP (1999) Dystroglycan inside and out. Curr Opin Cell Biol 11:602-607
51. Isfort RJ (2002) Proteomic analysis of striated muscle. J Chromatogr B 771:155-165
52. Kinali M, Arechavala-Gomeza V, Feng L, Cirak S, Hunt D, Adkin C, Guglieri M, Ashton E, Abbs S, Nihoyannopoulos P, Garralda ME, Rutherford M, McCulley C, Popplewell L, Graham IR, Dickson G, Wood MJ, Wells DJ, Wilton SD, Kole R, Straub V, Bushby K, Sewry C, Morgan JE, Muntoni F (2009) Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a singleblind, placebo-controlled, dose-escalation, proof-of-concept study. Lancet Neurol 8:918-928
53. Koenig M, Kunkel LM (1990) Detailed analysis of the repeat domain of dystrophin reveals four potential hinge segments that may confer flexibility. J Biol Chem 265:4560-4566
54. Koenig M, Monaco AP, Kunkel LM (1988) The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell 53:219-226
55. Krueger J, Kunert-Keil C, Bisping F, Brinkmeier H (2008) Transient receptor potential cation channels in normal and dystrophic mdx muscle. Neuromuscul Disord 18:501-513
56. Lovering RM, Michaelson L, Ward CW (2009) Malformed mdx myofibers have normal cytoskeletal architecture yet altered EC coupling and stress-induced Ca2+ signaling. Am J Physiol Cell Physiol 297:C571-C580
57. Mallouk N, Jacquemond V, Allard B (2000) Elevated subsarcolemmal Ca2+ in mdx mouse skeletal muscle fibres detected with Ca2+ - activated K+ channels. Proc Natl Acad Sci USA 97:4950-4955
58. Manzur AY, Muntoni F (2009) Diagnosis and new treatments in muscular dystrophies. J Neurol Neurosurg Psychiatry 80:706-714
59. Manzur AY, Kuntzer T, Pike M, Swan A (2008) Glucocorticoid corticosteroids for Duchenne muscular dystrophy. Cochrane Database Syst Rev (1):CD003725
60. Marouga R, David S, Hawkins E (2005) The development of the DIGE system: 2D fluorescence difference gel analysis technology. Anal Bioanal Chem 382:669-678
61. Marques MJ, Ferretti R, Vomero VU, Minatel E, Neto HS (2007) Intrinsic laryngeal muscles are spared from myonecrosis in the mdx mouse model of Duchenne muscular dystrophy. Muscle Nerve 35:349-353
62. Matsumura CY, Pertille A, Albuquerque TC, Santo Neto H, Marques MJ (2009) Diltiazem and verapamil protect dystrophin-deficient muscle fibers of MDX mice from degeneration: a potential role in calcium buffering and sarcolemmal stability. Muscle Nerve 39:167-176
63. Miller G, Wang EL, Nassar KL, Peter AK, Crosbie RH (2007) Structural and functional analysis of the sarcoglycan-sarcospan subcomplex. Exp Cell Res 313:639-651
64. Minden JS, Dowd SR, Meyer HE, Stuehler K (2009) Difference gel electrophoresis. Electrophoresis 30:S156-S161
65. Monaco AP, Neve RL, Colletti-Feener C, Bertelson CJ, Kurnit DM, Kunkel LM (1986) Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene. Nature 323:646-650
66. Muir LA, Chamberlain JS (2009) Emerging strategies for cell and gene therapy of the muscular dystrophies. Expert Rev Mol Med 11:e18
67. Nakamura A, Takeda S (2009) Exon-skipping therapy for Duchenne muscular dystrophy. Neuropathology 29:494-501
68. Nicholl ID, Quinlan RA (1994) Chaperone activity of alphacrystallins modulates intermediate filament assembly. EMBO J 13:945-953
69. Ohlendieck K (1996) Towards an understanding of the dystrophinglycoprotein complex: linkage between the extracellular matrix and the subsarcolemmal membrane cytoskeleton. Eur J Cell Biol 69:1-10
70. Ohlendieck K, Campbell KP (1991) Dystrophin constitutes 5% of membrane cytoskeleton in skeletal muscle. FEBS Lett 283:230-234
71. Ohlendieck K, Ervasti JM, Matsumura K, Kahl SD, Leveille CJ, Campbell KP (1991a) Dystrophin-related protein is localized to neuromuscular junctions of adult skeletal muscle. Neuron 7:499-508
72. Ohlendieck K, Ervasti JM, Snook JB, Campbell KP (1991b) Dystrophin glycoprotein complex is highly enriched in skeletal muscle sarcolemma. J Cell Biol 112:135-148
73. Ohlendieck K, Matsumura K, Ionasescu VV, Towbin JA, Bosch P, Weinstein SL, Sernett SW, Campbell KP (1993) Duchenne muscular dystrophy: deficiency of dystrophin-associated proteins in the sarcolemma. Neurology 43:795-800 (Pubitemid 23121977)
74. Ozawa E, Mizuno Y, Hagiwara Y, Sasaoka T, Yoshida M (2005) Molecular and cell biology of the sarcoglycan complex. Muscle Nerve 32:563-576
75. Piccolo F, Moore SA, Mathews KD, Campbell KP (2002) Limbgirdle muscular dystrophies. Adv Neurol 88:273-291
76. Pieper R, Gatlin CL, Makusky AJ, Russo PS, Schatz CR, Miller SS, Su Q, McGrath AM, Estock MA, Parmar PP, Zhao M, Huang ST, Zhou J, Wang F, Esquer-Blasco R, Anderson NL, Taylor J, Steiner S (2003) The human serum proteome: display of nearly 3700 chromatographically separated protein spots on twodimensional electrophoresis gels and identification of 325 distinct proteins. Proteomics 3:1345-1364
77. Rabilloud T, Vaezzadeh AR, Potier N, Lelong C, Leize-Wagner E, Chevallet M (2009) Power and limitations of electrophoretic separations in proteomics strategies. Mass Spectrom Rev 28:816-843
78. Rees ML, Lien CF, Gorecki DC (2007) Dystrobrevins in muscle and non-muscle tissues. Neuromuscul Disord 17:123-134
79. Sicinski P, Geng Y, Ryder-Cook AS, Barnard EA, Darlison MG, Barnard PJ (1989) The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science 244:1578-1580
80. Stedman HH, Sweeney HL, Shrager JB, Maguire HC, Panettieri RA, Petrof B, Narusawa M, Leferovich JM, Sladky JT, Kelly AM (1991) The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature 352:536-539
81. Teichmann MD, Wegner FV, Fink RH, Chamberlain JS, Launikonis BS, Martinac B, Friedrich O (2008) Inhibitory control over Ca2+ sparks via mechanosensitive channels is disrupted in dystrophin deficient muscle but restored by mini-dystrophin expression. PLoS One 3:e3644
82. Thomas LB, Joseph GL, Adkins TD, Andrade FH, Stemple JC (2008) Laryngeal muscles are spared in the dystrophin deficient mdx mouse. J Speech Lang Hear Res 51:586-595
83. Torres LFB, Duchen LW (1987) The mutant mdx: inherited myopathy in the mouse. Brain 110:269-299
84. Turk R, Sterrenburg E, de Meijer EJ, van Ommen GJ, den Dunnen JT, 't Hoen PA (2005) Muscle regeneration in dystrophin-deficient mdx mice studied by gene expression profiling. BMC Genomics 6:e98
85. Turner PR, Schultz R, Ganguly B, Steinhardt RA (1993) Proteolysis results in altered leak channel kinetics and elevated free calcium in mdx muscle. J Membr Biol 133:243-251
86. van Ommen GJ, van Deutekom J, Aartsma-Rus A (2008) The therapeutic potential of antisense-mediated exon skipping. Curr Opin Mol Ther 10:140-149
87. Vandebrouck C, Martin D, Colson-Van Schoor M, Debaix H, Gailly P (2002) Involvement of TRPC in the abnormal calcium influx observed in dystrophic (mdx) mouse skeletal muscle fibers. J Cell Biol 158:1089-1096
88. Viswanathan S, Unlu M, Minden JS (2006) Two-dimensional difference gel electrophoresis. Nat Protoc 1:1351-1358
89. Wilton SD, Fletcher S (2008) Exon skipping and Duchenne muscular dystrophy: hope, hype and how feasible? Neurol India 56:254-262
90. Wittmann-Liebold B, Graack HR, Pohl T (2006) Two-dimensional gel electrophoresis as tool for proteomics studies in combination with protein identification by mass spectrometry. Proteomics 6:4688-4703
91. Woods CE, Novo D, DiFranco M, Vergara JL (2004) The action potential-evoked sarcoplasmic reticulum calcium release is impaired in mdx mouse muscle fibres. J Physiol 557:59-75
92. Zaluzec EJ, Gage DA, Watson JT (1995) Matrix-assisted laser desorption ionization mass spectrometry: applications in peptide and protein characterization. Protein Expr Purif 6:109-123
93. Zhang SZ, Xie HQ, Xu Y, Li XQ, Wei RQ, Zhi W, Deng L, Qiu L, Yang ZM (2008) Regulation of cell proliferation by fast myosin light chain 1 in myoblasts derived from extraocular muscle, diaphragm and gastrocnemius. Exp Biol Med 233:1374-1384